• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与1型人类免疫缺陷病毒病毒粒子结合并中和其活性的17氨基酸V3环特异性微抗体的特性及作用机制

Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions.

作者信息

Jackson N A, Levi M, Wahren B, Dimmock N J

出版信息

J Gen Virol. 1999 Jan;80 ( Pt 1):225-236. doi: 10.1099/0022-1317-80-1-225.

DOI:10.1099/0022-1317-80-1-225
PMID:9934706
Abstract

Only two virus-neutralizing peptide microantibodies (MicroAbs) have been described and little is known about their mode of action. This report concerns a 17 amino acid cyclized MicroAb, derived from the third complementarity-determining region of the heavy chain of MAb F58 (IgG1), that recognizes the same minimum epitope in the V3 loop of the gp120 envelope protein of human immunodeficiency virus type 1 (HIV-1) as the MAb. The MicroAb was able to bind to and neutralize free virus particles. It was up to 5-fold more efficient in mass terms than F58 IgG and its neutralization rate on a molar basis was only 32-fold lower. The mechanism of neutralization of the MicroAb was also investigated. A high level of neutralization (99%) occurred without any significant decrease in attachment of virus to target C8166 cells. Neutralized virus attached to CD4, the HIV-1 primary receptor. Fusion of virions to cells was partially inhibited by the MicroAb, whereas F58 IgG has been shown to inhibit fusion significantly. Thus, neutralization by the MicroAb appears to be mediated, at least in part, by inhibition of fusion. Control peptides, in which the tyrosine at position 5 or 6 was deleted or changed to phenylalanine, showed no antiviral activity, attesting to the specificity of interaction of the MicroAb with the virion. It therefore appears that the MicroAb acts like an immunoglobulin. The data also show that the MicroAb/MAb F58 epitope on the V3 loop is not involved in attachment of virus to CD4 but is required for subsequent events in early infection.

摘要

仅描述了两种病毒中和肽微抗体(MicroAbs),对其作用模式了解甚少。本报告涉及一种由单克隆抗体F58(IgG1)重链的第三个互补决定区衍生而来的17个氨基酸的环化微抗体,它在人免疫缺陷病毒1型(HIV-1)的gp120包膜蛋白的V3环中识别与单克隆抗体相同的最小表位。该微抗体能够结合并中和游离病毒颗粒。按质量计算,其效率比F58 IgG高5倍,其摩尔中和率仅低32倍。还研究了该微抗体的中和机制。在病毒与靶细胞C8166的附着没有任何显著减少的情况下,发生了高水平的中和(99%)。中和后的病毒附着于HIV-1的主要受体CD4。微抗体部分抑制了病毒粒子与细胞的融合,而F58 IgG已被证明能显著抑制融合。因此,微抗体的中和作用似乎至少部分是由融合抑制介导的。在第5或6位酪氨酸被缺失或替换为苯丙氨酸的对照肽没有显示出抗病毒活性,这证明了微抗体与病毒粒子相互作用的特异性。因此,微抗体的作用似乎类似于免疫球蛋白。数据还表明,V3环上的微抗体/单克隆抗体F58表位不参与病毒与CD4的附着,但在早期感染的后续事件中是必需的。

相似文献

1
Properties and mechanism of action of a 17 amino acid, V3 loop-specific microantibody that binds to and neutralizes human immunodeficiency virus type 1 virions.一种与1型人类免疫缺陷病毒病毒粒子结合并中和其活性的17氨基酸V3环特异性微抗体的特性及作用机制
J Gen Virol. 1999 Jan;80 ( Pt 1):225-236. doi: 10.1099/0022-1317-80-1-225.
2
Analysis of a 17-amino acid residue, virus-neutralizing microantibody.对一种17个氨基酸残基的病毒中和微抗体的分析。
J Gen Virol. 2005 Jun;86(Pt 6):1791-1800. doi: 10.1099/vir.0.80812-0.
3
Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1.两种中和性抗V3单克隆抗体通过影响1型人类免疫缺陷病毒的不同功能发挥作用。
J Gen Virol. 1996 Dec;77 ( Pt 12):2931-41. doi: 10.1099/0022-1317-77-12-2931.
4
Rapid analysis of epitope-paratope interactions between HIV-1 and a 17-amino-acid neutralizing microantibody by electrospray ionization mass spectrometry.通过电喷雾电离质谱法快速分析HIV-1与一种17氨基酸中和微抗体之间的表位-互补位相互作用
Eur J Biochem. 1998 Nov 15;258(1):164-9. doi: 10.1046/j.1432-1327.1998.2580164.x.
5
A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.一种新型抗人免疫缺陷病毒1型gp120的人源抗体依赖于V1、V2和V3环,并有助于界定广泛中和抗体免疫球蛋白G1 b12的表位。
J Virol. 2003 Jun;77(12):6965-78. doi: 10.1128/jvi.77.12.6965-6978.2003.
6
A human IgG1 (b12) specific for the CD4 binding site of HIV-1 neutralizes by inhibiting the virus fusion entry process, but b12 Fab neutralizes by inhibiting a postfusion event.一种针对HIV-1 CD4结合位点的人IgG1(b12)通过抑制病毒融合进入过程发挥中和作用,而b12 Fab则通过抑制融合后事件发挥中和作用。
Virology. 1997 Jul 7;233(2):313-26. doi: 10.1006/viro.1997.8547.
7
Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.抗体与原发性人类免疫缺陷病毒1型(HIV-1)分离株的病毒体相关gp120分子的结合:对巨噬细胞和外周血单核细胞HIV-1感染的影响。
Virology. 1997 Mar 17;229(2):360-9. doi: 10.1006/viro.1997.8443.
8
Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.与HIV-1 gp120 V3环基部反应的同种型和亚类转换的人单克隆抗体的表达及功能活性
AIDS Res Hum Retroviruses. 2003 Jul;19(7):597-607. doi: 10.1089/088922203322230969.
9
The v3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope.v3环在大多数1型人类免疫缺陷病毒原始分离株的表面是可及的,并作为一个中和表位。
J Virol. 2004 Mar;78(5):2394-404. doi: 10.1128/jvi.78.5.2394-2404.2004.
10
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.在CCR5限制性而非CXCR4利用型的原发性人类免疫缺陷病毒1型毒株的天然包膜糖蛋白寡聚体中,一个保守的、CD4诱导性V3环中和表位的隐秘性质。
J Virol. 2005 Jun;79(11):6957-68. doi: 10.1128/JVI.79.11.6957-6968.2005.

引用本文的文献

1
Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.抗体互补决定区(CDR)可表现出不同的抗菌、抗病毒和抗肿瘤活性。
PLoS One. 2008 Jun 11;3(6):e2371. doi: 10.1371/journal.pone.0002371.
2
Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.血凝素1特异性免疫球蛋白G和Fab分子通过抑制早期融合事件介导甲型流感病毒的附着后中和作用。
J Virol. 2001 Nov;75(21):10208-18. doi: 10.1128/JVI.75.21.10208-10218.2001.